Richard Gauci

Murdoch, WA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

SUBDUE-3: SUB-urothelial DUrvalumab-89zirconium injEction; a phase 0 biodistribution study protocol.

SUBDUE-3: SUB-urothelial DUrvalumab-89zirconium injEction; a phase 0 biodistribution study protocol.

Journal: BJU international

Published: February 12, 2026

Prolonged Survival in Anaplastic Thyroid Cancer: Insights From Multi-Modal Treatment.

Prolonged Survival in Anaplastic Thyroid Cancer: Insights From Multi-Modal Treatment.

Journal: Asia-Pacific journal of clinical oncology

Published: September 01, 2025

Malignancy Risk Stratification in FDG-PET Avid Adrenal Lesions: Diagnostic Utility and Predictive Factors.

Malignancy Risk Stratification in FDG-PET Avid Adrenal Lesions: Diagnostic Utility and Predictive Factors.

Journal: ANZ journal of surgery

Published: June 30, 2025

Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions.

Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions.

Journal: Cancers

Published: December 04, 2024

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer.

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer.

Journal: BJUI compass

Published: April 17, 2023

89Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma.

89Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma.

Journal: BMJ open

Published: April 16, 2022

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours.

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours.

Journal: Cancer medicine

Published: August 05, 2021

A Case Report of Syndromic Multinodular Goitre in Adolescence: Exploring the Phenotype Overlap between Cowden and DICER1 Syndromes.

A Case Report of Syndromic Multinodular Goitre in Adolescence: Exploring the Phenotype Overlap between Cowden and DICER1 Syndromes.

Journal: European thyroid journal

Published: February 14, 2017

Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis.

Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis.

Journal: Journal of diabetes and its complications

Published: December 29, 2016

Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men.

Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 04, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026